TY - JOUR
T1 - Understanding the Risk of Using Medications for Attention Deficit Hyperactivity Disorder with Respect to Physical Growth and Cardiovascular Function
AU - Vitiello, Benedetto
PY - 2008/4
Y1 - 2008/4
N2 - The effects of stimulant medications and atomoxetine on physical growth and on cardiovascular function are reviewed in light of the most recent data, with attention to clinical implications and research needs. Although these medications have a favorable benefit/risk profile and do not induce clinically significant changes in growth or cardiovascular function in the majority of cases, careful patient monitoring is needed to identify individuals at risk for negative outcomes. More research is needed to elucidate the mechanism of growth suppression to estimate better the risk for rare but life-threatening events and test the effectiveness of monitoring procedures.
AB - The effects of stimulant medications and atomoxetine on physical growth and on cardiovascular function are reviewed in light of the most recent data, with attention to clinical implications and research needs. Although these medications have a favorable benefit/risk profile and do not induce clinically significant changes in growth or cardiovascular function in the majority of cases, careful patient monitoring is needed to identify individuals at risk for negative outcomes. More research is needed to elucidate the mechanism of growth suppression to estimate better the risk for rare but life-threatening events and test the effectiveness of monitoring procedures.
UR - http://www.scopus.com/inward/record.url?scp=39149117391&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39149117391&partnerID=8YFLogxK
U2 - 10.1016/j.chc.2007.11.010
DO - 10.1016/j.chc.2007.11.010
M3 - Review article
C2 - 18295156
AN - SCOPUS:39149117391
SN - 1056-4993
VL - 17
SP - 459
EP - 474
JO - Child and Adolescent Psychiatric Clinics of North America
JF - Child and Adolescent Psychiatric Clinics of North America
IS - 2
ER -